VivoSim Labs, Inc. (VIVS)
0.2811
0.00 (0.00%)
USD |
NASDAQ |
Sep 14, 14:57
VivoSim Labs Enterprise Value : -0.4497M for Sept. 11, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 11, 2026 | -0.4497M |
| September 10, 2026 | -0.3963M |
| September 09, 2026 | -0.4756M |
| September 08, 2026 | -0.4542M |
| September 04, 2026 | -0.4653M |
| September 03, 2026 | -0.4628M |
| September 02, 2026 | -0.4602M |
| September 01, 2026 | -0.4637M |
| August 31, 2026 | -0.4232M |
| August 28, 2026 | -0.4427M |
| August 27, 2026 | -0.4181M |
| August 26, 2026 | -0.4245M |
| August 25, 2026 | -0.4225M |
| August 24, 2026 | -0.4213M |
| August 21, 2026 | -0.4404M |
| August 20, 2026 | -0.4676M |
| August 19, 2026 | -0.4682M |
| August 18, 2026 | -0.4641M |
| August 17, 2026 | -0.3382M |
| August 14, 2026 | -0.3238M |
| August 13, 2026 | -0.306M |
| August 12, 2026 | -0.2932M |
| August 11, 2026 | -0.2277M |
| August 10, 2026 | -0.1903M |
| August 07, 2026 | 0.1409M |
| Date | Value |
|---|---|
| August 06, 2026 | -0.3002M |
| August 05, 2026 | -0.1929M |
| August 04, 2026 | -0.1817M |
| August 03, 2026 | -0.2852M |
| July 31, 2026 | -0.2532M |
| July 30, 2026 | -0.121M |
| July 29, 2026 | -0.2523M |
| July 28, 2026 | -0.1341M |
| July 27, 2026 | -0.1089M |
| July 24, 2026 | -0.0159M |
| July 23, 2026 | 0.0834M |
| July 22, 2026 | 0.1192M |
| July 21, 2026 | 0.0834M |
| July 20, 2026 | 0.2588M |
| July 17, 2026 | 0.4955M |
| July 16, 2026 | 0.606M |
| July 15, 2026 | 1.370M |
| July 14, 2026 | 1.313M |
| July 13, 2026 | 1.230M |
| July 10, 2026 | 1.454M |
| July 09, 2026 | 1.205M |
| July 08, 2026 | 1.147M |
| July 07, 2026 | 1.533M |
| July 06, 2026 | 1.793M |
| July 02, 2026 | 1.776M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Agenus, Inc. | 560.41M |
| Amgen, Inc. | 247.31B |
| Anika Therapeutics, Inc. | 266.01M |
| BioCryst Pharmaceuticals, Inc. | 2.556B |
| Imunon, Inc. | 7.840M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.338M |
| Revenue (Quarterly) | 0.018M |
| Total Expenses (Quarterly) | 1.356M |
| EPS Diluted (Quarterly) | -0.2554 |
| Gross Profit Margin (Quarterly) | -122.2% |
| Profit Margin (Quarterly) | -7.43K% |
| Earnings Yield | -1.59K% |
| Normalized Earnings Yield | -1657.31 |